retatrutide and semaglutide vs. Retatrutide: A Comparison Retatrutide vs Semaglutide and Tirzepatide:
Description
Cardiovasc Diabetol 21(1):232 Hu Y et al (2022) Cost-effectiveness analysis of 4 GLP-1RAs in the treatment of obesity in a US setting
Fr optimal skerhet, srskilt vid lngvarig anvndning ver sex mnader, rekommenderas regelbundna kontroller med vrdpersonal fr att vervaka metaboliska vrden
Current treatments for nonalcoholic steatohepatitis are not efficient and the disease can progress to cirrhosis and liver cancernew therapies are clearly needed
Current evidence suggests that risk correlates more with the magnitude of weight loss than with a specific agent
No retatrutide has not received MHRA marketing authorisation and is not available through NHS prescribing
